Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 337)
Posted On: 04/26/2021 8:28:13 PM
Post# of 36564
Posted By: pacsurg21
https://podcasts.apple.com/us/podcast/radiola...0512649960

Worth a listen. We are not out of the woods yet and what I heard in this is that off-target triggers can contribute to strengthening the evolution of the virus. ii-key works by disrupting and replacing the cell with ii-key, so it has a very strong potential to disrupt the virus in a more targeted way without creating the off-target variants. I wonder how we sign up for phase 1 trials, or for a phase 1 booster trial if it is necessary to separate them.













(2)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site